Trials / Completed
CompletedNCT06012578
Study Evaluating ISM5411 Administered Orally to Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate Safety, Tolerability, Pharmacokinetics and Food Effect of ISM5411 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- InSilico Medicine Hong Kong Limited · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to learn about ISM5411 in healthy subjects. The primary objective is to evaluate the safety and tolerability of single and multiple oral doses of ISM5411 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ISM5411 | Investigational Drug |
| DRUG | Placebo | ISM5411 Matching Placebo |
Timeline
- Start date
- 2023-11-08
- Primary completion
- 2024-09-04
- Completion
- 2024-09-04
- First posted
- 2023-08-25
- Last updated
- 2024-11-07
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06012578. Inclusion in this directory is not an endorsement.